On August 9, 2016, Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727) cancelled the transaction. The cancellation has been approved at the 6th extraordinary session of the 3rd directorate of the company. The company has withdrawn its application documents from China Regulatory Securities Commission.